Fluoroquinolone Antibiotics are linked to Mental Health Side Effects

HomeBlogDangerous DrugsFluoroquinolone Antibiotics are linked to Mental Health Side Effects

Fluoroquinolone Antibiotics are linked to Mental Health Side Effects

FLQ linked to Mental Health Side Effects

July 12, 2018 Categories: Dangerous Drugs, FDA updates

Fluoroquinolone Antibiotics are linked to Mental Health Side Effects

FDA posted a label changes request for FLQ on July 10th of 2018.

FLQs such as Levaquin, Cipro, Avelox and others can cause the following side effects:

disturbances in attention
disorientation
agitation
nervousness
memory impairment
serious disturbances in mental abilities called delirium.

“FDA is strengthening the current warnings in the prescribing information that fluoroquinolone antibiotics may cause significant decreases in blood sugar and certain mental health side effects…
The new label changes will add that low blood sugar levels, also called hypoglycemia, can lead to coma and the new label will also make the mental health side effects more prominent and more consistent across the systemic fluoroquinolone drug class. “

U.S. Food and Drug Administration

Your Comment Cancel reply

Recent Updates

Non-Hodgkin lymphoma patient who was working with Roundup is suing Monsanto

It has been a few years since Roundup®, a product of Monsanto, was reportedly linked to a serious disease called non-Hodgkin lymphoma. People who worked with the weed-killer Roundup® across the United States were exposed to glyphosate, which is the main ingredient in the most popular herbicide in the country. Case of DeWayne Johnson against...

July 25, 2018

Gadolinium MRI Poisoning Investigation

The FDA issued a safety alert in December 2017, stating that some patients who received a gadolinium-based contrast during an MRI procedure, may retain the gadolinium in their bodies for months, or even for years, causing serious side effects. Gadolinium is commonly used in MRIs to enhance the images the test provides. Gadolinium is a...

July 18, 2018

FDA recalls Valsartan – Antihypertensive drug

Valsartan is mainly used for treatment of high blood pressure, congestive heart failure, and after a heart attack. The FDA has announced a recall of several drugs that contain the heart drug valsartan because a possible carcinogen NDMA (N-Nitrosodimethylamine) that was found in the recalled products. NDMA, which was found in the valsartan products, could...

July 17, 2018